title: Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis.
authors.forename: D
authors.initials: D
authors.lastname: Sacerdoti
authors.forename: C
authors.initials: C
authors.lastname: Merkel
authors.forename: A
authors.initials: A
authors.lastname: Gatta
mesh_terms: D004932:Esophageal and Gastric Varices / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy*; D008103:Liver Cirrhosis / Q000150:complications* / Q000453:epidemiology; D008107:Liver Diseases / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D008297:Male; D009248:Nadolol / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D009248:Nadolol